210 related articles for article (PubMed ID: 16143162)
1. Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.
Richards DA
Semin Oncol; 2005 Aug; 32(4 Suppl 6):S9-13. PubMed ID: 16143162
[TBL] [Abstract][Full Text] [Related]
2. Recent updates on the role of chemotherapy in pancreatic cancer.
Burris HA
Semin Oncol; 2005 Aug; 32(4 Suppl 6):S1-3. PubMed ID: 16143160
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-based combination treatment of pancreatic cancer.
Heinemann V
Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
Heinemann V
Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
6. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.
Heinemann V; Boeck S; Hinke A; Labianca R; Louvet C
BMC Cancer; 2008 Mar; 8():82. PubMed ID: 18373843
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine: progress in the treatment of pancreatic cancer.
Heinemann V
Oncology; 2001; 60(1):8-18. PubMed ID: 11150902
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel in the management of advanced pancreatic cancer.
Lopes G; Rocha Lima CM
Semin Oncol; 2005 Apr; 32(2 Suppl 4):S10-23. PubMed ID: 16015551
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.
Kozuch P; Petryk M; Evans A; Bruckner HW
Surg Clin North Am; 2001 Jun; 81(3):683-90. PubMed ID: 11459281
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I study.
Sun W; Haller D
Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):16-9. PubMed ID: 14569842
[TBL] [Abstract][Full Text] [Related]
11. [Non-surgical treatment for pancreatic cancer].
Okusaka T; Ueno H; Ikeda M; Morizane C
Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):391-7. PubMed ID: 16629457
[No Abstract] [Full Text] [Related]
12. A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.
Hu J; Zhao G; Wang HX; Tang L; Xu YC; Ma Y; Zhang FC
J Hematol Oncol; 2011 Mar; 4():11. PubMed ID: 21439076
[TBL] [Abstract][Full Text] [Related]
13. The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.
Oettle H; Arnold D; Hempel C; Riess H
Anticancer Drugs; 2000 Nov; 11(10):771-86. PubMed ID: 11142685
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.
Oztop I; Yilmaz U; Yavuzsen T; Yaren A; Tarhan O; Sagol O; Coker A; Alakavuklar M
Chemotherapy; 2004 Jun; 50(3):127-32. PubMed ID: 15282439
[TBL] [Abstract][Full Text] [Related]
15. Advanced pancreatic cancer: is there a role for combination therapy?
Kulke MH
Expert Rev Anticancer Ther; 2003 Oct; 3(5):729-39. PubMed ID: 14599095
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs in pancreatic cancer.
Ducreux M; Boige V; Malka D
Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
[TBL] [Abstract][Full Text] [Related]
17. [The update on pancreatic cancer chemotherapy].
Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A
Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647
[TBL] [Abstract][Full Text] [Related]
18. [Pancreatic carcinoma: progress in therapy].
Lordick F
Krankenpfl J; 2004; 42(5-6):158-9. PubMed ID: 15527223
[No Abstract] [Full Text] [Related]
19. Front-line therapy of advanced pancreatic cancer.
Kindler HL
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S33-6. PubMed ID: 16399428
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
Rocha Lima CM; Green MR; Rotche R; Miller WH; Jeffrey GM; Cisar LA; Morganti A; Orlando N; Gruia G; Miller LL
J Clin Oncol; 2004 Sep; 22(18):3776-83. PubMed ID: 15365074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]